
| Hongling Huang, Ph.D. Professor Email:honglinghuang@xmu.edu.cn |
Education
B.S. 2008, East China University of Science and Technology, Biotechnology;
Ph.D. 2013, Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Biochemistry and Molecular Biology;
Professional Experience
Postdoctoral Fellow, Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, 2013-2014;
Postdoctoral Fellow, KU Leuven, 2014-2016;
Postdoctoral Fellow/Senior Scientist, Department of Immunology, St. Jude Children’s Research Hospital, 2017-2021;
Professor, School of Life Sciences, Xiamen University, 2022 to Present.
Research Area
Our research interest lies in the immune signaling underlying the differentiation and function of T cells, a central cell type in adaptive immunity and cancer immunotherapy. We apply systems biology approaches, such as single cell RNA-sequencing (scRNA-seq), CRISPR screening and the integrative network analysis, to reconstruct molecular hubs for T cell fate decision in tumor, infection, and autoimmunity diseases as well as in heathy condition. Our work could shed light on our understanding of fundamental mechanisms of immune regulation and pave the way for better immunotherapy.
Selected Publications
1、Zhou, P#., H. Shi#, H. Huang#, X. Sun, S. Yuan, N. M. Chapman, J. P. Connelly, S. A. Lim, J. Saravia, A. Kc, S. M. Pruett-Miller and H. Chi* (2023). "Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer." Nature.
2、Guo, A.#, H. Huang#, Z. Zhu, M. J. Chen, H. Shi, S. Yuan, P. Sharma, J. P. Connelly, S. Liedmann, Y. Dhungana, Z. Li, D. Haydar, M. Yang, H. Beere, J. T. Yustein, C. DeRenzo, S. M. Pruett-Miller, J. C. Crawford, G. Krenciute, C. W. M. Roberts, H. Chi* and D. R. Green* (2022). "cBAF complex components and MYC cooperate early in CD8(+) T cell fate." Nature 607(7917): 135-141.
3、Huang, H.#, P. Zhou, J#. Wei, L. Long, H. Shi, Y. Dhungana, N. M. Chapman, G. Fu, J. Saravia, J. L. Raynor, S. Liu, G. Palacios, Y. D. Wang, C. Qian, J. Yu and H. Chi *(2021). "In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8(+) T cell fate decisions." Cell 184(5): 1245-1261 e1221.
4、Huang, H#., L. Long, P#. Zhou, N#. M. Chapman and H. Chi* (2020). "mTOR signaling at the crossroads of environmental signals and T-cell fate decisions." Immunol Rev 295(1): 15-38.
5、Huang, H., S. Vandekeere, J. Kalucka, L. Bierhansl, A. Zecchin, U. Bruning, A. Visnagri, N. Yuldasheva, J. Goveia, B. Cruys, K. Brepoels, S. Wyns, S. Rayport, B. Ghesquiere, S. Vinckier, L. Schoonjans, R. Cubbon, M. Dewerchin, G. Eelen and P. Carmeliet (2017). "Role of glutamine and interlinked asparagine metabolism in vessel formation." Embo j 36(16): 2334-2352.
6、Huang, H. L., S. Wang, M. X. Yin, L. Dong, C. Wang, W. Wu, Y. Lu, M. Feng, C. Dai, X. Guo, L. Li, B. Zhao, Z. Zhou, H. Ji, J. Jiang, Y. Zhao, X. Y. Liu and L. Zhang (2013). "Par-1 regulates tissue growth by influencing hippo phosphorylation status and hippo-salvador association." PLoS Biol 11(8): e1001620.
7、Su, W., J. Saravia, I. Risch, S. Rankin, C. Guy, N. M. Chapman, H. Shi, Y. Sun, A. Kc, W. Li, H. Huang, S. A. Lim, H. Hu, Y. Wang, D. Liu, Y. Jiao, P. C. Chen, H. Soliman, K. K. Yan, J. Zhang, P. Vogel, X. Liu, G. E. Serrano, T. G. Beach, J. Yu, J. Peng and H. Chi* (2023). "CXCR6 orchestrates brain CD8(+) T cell residency and limits mouse Alzheimer's disease pathology." Nat Immunol 24(10): 1735-1747.
8、Long, L., J. Wei, S. A. Lim, J. L. Raynor, H. Shi, J. P. Connelly, H. Wang, C. Guy, B. Xie, N. M. Chapman, G. Fu, Y. Wang, H. Huang, W. Su, J. Saravia, I. Risch, Y. D. Wang, Y. Li, M. Niu, Y. Dhungana, A. Kc, P. Zhou, P. Vogel, J. Yu, S. M. Pruett-Miller, J. Peng and H. Chi* (2021). "CRISPR screens unveil signal hubs for nutrient licensing of T cell immunity." Nature 600(7888): 308-313.
9、Fu, G., C. S. Guy, N. M. Chapman, G. Palacios, J. Wei, P. Zhou, L. Long, Y. D. Wang, C. Qian, Y. Dhungana, H. Huang, A. Kc, H. Shi, S. Rankin, S. A. Brown, A. Johnson, R. Wakefield, C. G. Robinson, X. Liu, A. Sheyn, J. Yu, S. Jackowski and H. Chi*(2021). "Metabolic control of TFH cells and humoral immunity by phosphatidylethanolamine." Nature 595(7869): 724-729.
10、Wei, J., L. Long, W. Zheng, Y. Dhungana, S. A. Lim, C. Guy, Y. Wang, Y. D. Wang, C. Qian, B. Xu, A. Kc, J. Saravia, H. Huang, J. Yu, J. G. Doench, T. L. Geiger and H. Chi* (2019). "Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy." Nature 576(7787): 471-476.
11、Eelen, G., C. Dubois, A. R. Cantelmo, J. Goveia, U. Bruning, M. DeRan, G. Jarugumilli, J. van Rijssel, G. Saladino, F. Comitani, A. Zecchin, S. Rocha, R. Chen, H. Huang, S. Vandekeere, J. Kalucka, C. Lange, F. Morales-Rodriguez, B. Cruys, L. Treps, L. Ramer, S. Vinckier, K. Brepoels, S. Wyns, J. Souffreau, L. Schoonjans, W. H. Lamers, Y. Wu, J. Haustraete, J. Hofkens, S. Liekens, R. Cubbon, B. Ghesquiere, M. Dewerchin, F. L. Gervasio, X. Li, J. D. van Buul, X. Wu and P. Carmeliet* (2018). "Role of glutamine synthetase in angiogenesis beyond glutamine synthesis." Nature 561(7721): 63-69.
12、Wong, B. W., X. Wang, A. Zecchin, B. Thienpont, I. Cornelissen, J. Kalucka, M. Garcia-Caballero, R. Missiaen, H. Huang, U. Bruning, S. Blacher, S. Vinckier, J. Goveia, M. Knobloch, H. Zhao, C. Dierkes, C. Shi, R. Hagerling, V. Moral-Darde, S. Wyns, M. Lippens, S. Jessberger, S. M. Fendt, A. Luttun, A. Noel, F. Kiefer, B. Ghesquiere, L. Moons, L. Schoonjans, M. Dewerchin, G. Eelen, D. Lambrechts and P. Carmeliet* (2017). "The role of fatty acid beta-oxidation in lymphangiogenesis." Nature 542(7639): 49-54.